Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial

Warren, R. A., Carew, A. S., Andreou, P., Herman, C., Levy, A. P., Ginsberg, H. N., Sapp, J., Rimm, E. B., Kirkland, S., & Cahill, L. E. (2021). Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial. Diabetes Care, 45(1), 241–250. https://doi.org/10.2337/dc21-1429

Authors:

Rachel A. Warren

Allie S. Carew

Pantelis Andreou

Susan Kirkland

Leah E. Cahill

Christine Herman

John Sapp

Andrew P. Levy

Henry N. Ginsberg

Eric B. Rimm

Affiliated Authors: